Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation

2013

Treatment of Breast and Lung Cancer Cells with a N-7 Benzyl Guanosine Monophosphate Tryptamine Phosphoramidate Pronucleotide (4Ei-1) Results in Chemosensitization to Gemcitabine and Induced eIF4E Proteasomal Degradation
Molecular Pharmaceutics (2013)

The articles on our website include some of the publications and papers authored by our attorneys, both before and after they joined our firm. The content of these articles should not be taken as legal advice. The views and opinions expressed in this article are those of the author(s) and do not necessarily reflect the views or official position of Robins Kaplan LLP.

Disclaimer

Shui Li

Associate

Related Publications

April 2, 2021
Spring 2021
Fiduciary or Foe? Revisiting Meinhard v. Salmon
Denise Rahne, Samia Young - The Robins Kaplan Spotlight, Vol. 6, No. 1
Spring 2021
Shareholder Risks in Mergers and Acquisitions
David Martinez, Jason Fair - The Robins Kaplan Spotlight, Vol. 6, No. 1
Spring 2021
When the Business Is All in the Family
Anne Lockner - The Robins Kaplan Spotlight, Vol. 6, No. 1
March 26, 2021
Trends In Video Game Company Quests To Arbitrate Cases
Matthew Woods, Austin Miller - Law360
Back to Top